Answers are grounded in this paper and cite their sources.
Background: Glypican-3 (GPC3), a cell surface glycoprotein, regulates cell growth and exhibits increased expression in hepatocellular carcinoma (HCC) and squamous non-small cell lung cancer (SQ-NSCLC). This study developed an artificial intelligence (AI) algorithm for predicting GPC3 expression to accelerate clinical trial enrollment, comparing it with manual immunohistochemistry (IHC) scoring.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: